Defense Advanced Research Projects AgencyTagged Content List

Restore and Maintain Warfighter Abilities

Relating to the restoration and optimization of human health

Showing 36 results for Health + Programs RSS
The Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT) program supports individual troop readiness and total force health protection by developing technologies to rapidly identify and respond to threats posed by natural and engineered diseases and toxins. A subset of ADEPT technologies specifically support use by personnel with minimal medical training, delivering centralized laboratory capabilities even in the low-resource environments typical of many military operations. The program is part of a portfolio of DARPA-funded research aimed at providing options for preempting or mitigating constantly evolving infectious disease threats.
The Battlefield Medicine program supports military readiness in far-forward deployed settings by overcoming logistical obstacles to manufacturing and delivery of urgently needed pharmaceutical products used to treat emerging threats.
The Biostasis program aims to extend the time for lifesaving medical treatment, often referred to as “the Golden Hour,” following traumatic injury or acute infection, thus increasing survivability for military personnel operating in far-forward conditions with limited access to medical professionals or trauma centers. To do so, Biostasis is developing novel chemical biology approaches that reversibly and controllably slow biological systems without cold-chain to stabilize and protect their functional capacity until medical intervention is possible.
As a result of combat exposure, warfighters may return home from deployments with psychological health challenges and find it difficult to reconnect with family and society at large. According to the Department of Veteran Affairs’ National Center for PTSD, studies show that between 12 and 25 percent of military personnel who had returned from Afghanistan and Iraq as of 2008 may suffer from PTSD. (1) Despite best efforts to improve awareness and care, additional studies reveal that only a small fraction of warfighters seek help dealing with psychological health issues.
The Dialysis-Like Therapeutics (DLT) program aims to support force protection and military readiness by improving critical care in low-resource environments and delivering a new tool for rapid response to emerging infectious disease threats. DLT specifically addresses a life-threatening blood infection known as sepsis, but DARPA is working to expand the DLT technology to also mitigate threats from harmful bacteria, viruses, fungi, and toxic agents in the blood.